Comparing two antibiotic treatments for joint infections caused by Staphylococcus
Official title: Rifampicin Combination Therapy Versus Targeted Antimicrobial Monotherapy in the Oral Antimicrobial Treatment Phase of Staphylococcal Prosthetic Joint Infection
Run by Leiden University Medical Center · NCT06172010 · Data updated 2026-11-12
This study tests whether a combination of two antibiotics can work better than just one to treat joint infections caused by Staphylococcus in adults with hip or knee infections.
Quick facts
| Phase | Phase 4 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 316 (estimated) |
| Sponsor | Leiden University Medical Center Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 13 sites (Leiden, Zuid Hollans and 12 other locations) |
| Status | Recruiting |
| Started | April 1, 2023 |
| Main results expected | March 2027 |
| Study ends | March 2028 |
| Registry record updated | December 15, 2023 |
| Trial ID | NCT06172010 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults over 18 with confirmed staphylococcal prosthetic hip or knee joint infections treated by the DAIR strategy.
✕Probably not a fit
Patients with contraindications to rifampicin, levofloxacin, or clindamycin, or those requiring long-term intravenous antibiotic treatment may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This multicenter clinical trial in the Netherlands aims to compare the effectiveness of rifampicin and levofloxacin combination therapy against clindamycin monotherapy in treating staphylococcal prosthetic joint infections. Patients aged 18 and older diagnosed with hip or knee infections will be randomized to receive either treatment during the oral antibiotic phase. The study will follow participants for 15 months to assess treatment success based on predefined clinical endpoints. The trial employs a pragmatic, randomized controlled design to evaluate the non-inferiority of the combination therapy.
Why it matters
Potential benefit: If successful, this study could provide a more effective treatment option for patients suffering from staphylococcal prosthetic joint infections.
How similar studies have gone: Previous studies have shown promise in using combination antibiotic therapies for similar infections, but this specific approach is being evaluated for the first time.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * \>18 years of age * Confirmed staphylococcal prosthetic hip or knee joint infection according to the current EBJIS 2021 definition of PJI * The causative agents are (or include) S. aureus or and/or Coagulase-negative staphylococci (CNS) * Treatment is according to the DAIR-procedure Exclusion Criteria: (i) a contra-indication for rifampicin (e.g. a resistant strain or proven allergic reaction or difficult drug-drug-interactions) (ii) complicated S. aureus bacteremia or concurrent endocarditis requiring long-term iv antibiotic treatment \> 2 weeks (iii) An infection for which there are no suitable antibiotic choices to permit Randomization between the two arms of the trial (for instance, where organisms are only sensitive to intravenous antibiotics) (iv) treatment failure before the start of oral therapy, (v) an unsatisfactory response to initial treatment leading to continuation of intravenous therapy beyond day 21, (vi) patients with an expected life expectancy \<12 months, (vii) patients with a tumor prosthesis (viii) patients receiving chemotherapy for active malignancy in the next 12 months (ix) patients who are scheduled in advance for chronic suppressive antibiotic therapy for \>12 months, (x) The patient is unlikely to comply with trial requirements following Randomization in the opinion of the investigator (xi) Pregnancy (xii) Patients who are not able to read or communicate in Dutch or English will be excluded from participating in this study
Where it's running
-
Lumc
Leiden, Zuid Hollans, Netherlands Recruiting -
Amsterdam UMC
Amsterdam, Netherlands Recruiting -
Olvg
Amsterdam, Netherlands Recruiting -
Umcg
Groningen, Netherlands Recruiting -
Spaarne gasthuis
Hoofddorp, Netherlands Recruiting -
Medisch Centrum Leeuwarden
Leeuwarden, Netherlands Recruiting
Show 7 more locations
-
Alrijne Ziekenhuis
Leiderdorp, Netherlands Recruiting -
Radboud UMC
Nijmegen, Netherlands Recruiting -
Sint maartenskliniek
Nijmegen, Netherlands Recruiting -
Elisabeth Tweesteden Ziekenhus
Tilburg, Netherlands Recruiting -
Stichting Isala Klinieken
Zwolle, Netherlands Recruiting -
Martini ziekenhuis
Groningen, Netherlands Not yet recruiting -
Erasmus MC
Rotterdam, Netherlands Not yet recruiting
Study contacts
- Study coordinator: Henk Scheper, MD
- Email: h.scheper@lumc.nl
- Phone: 071-5299239
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
How knee and hip joint replacements are doing over time
This observational study follows adults who have knee or hip replacements to see how their outcomes look over time after the surgery.
-
Population pharmacokinetics of rifampicin in staphylococcal osteoarticular infections
This study tests how rifampicin behaves in the body of adults with staphylococcal osteoarticular infections when given with levofloxacin or ciprofloxacin, to see how drug exposure relates to tolerance and outcomes.
-
Reducing bacterial contamination during primary shoulder replacement
This trial tests whether putting Prontosan antimicrobial gel on the dermal layer after the skin is cut can lower Cutibacterium acnes growth in men having primary shoulder replacement.
-
Methylene blue dye to measure how much irrigation clears contamination during knee replacement procedures
We will test whether putting methylene blue dye into the knee during replacement or DAIR procedures can show how much irrigation is needed to wash out contaminants.
-
PLG0206 irrigation to prevent repeat knee replacement infections after DAIR
This will test if washing the knee with PLG0206 during a DAIR procedure can lower the chance that a prosthetic knee infection comes back in adults who had a knee replacement.
-
Prosthetic joint infection patterns in critically ill patients who died
This project looks at health records of adults who died in intensive care with a hip, knee, or shoulder prosthetic joint infection from 2018–2022 to see common care paths and outcomes.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.